News Releases

Viewing Category: Chronic myeloid leukemia (CML)

• MONTREAL, CANADA — December 15, 2008

  Lower Dose Sprycel™ Approved for Patients With Chronic Phase CML

  New once daily dose retains efficacy and improves tolerability

  Categories: Chronic myeloid leukemia (CML) | Sprycel

• MONTREAL, CANADA — March 28, 2007

  Health Canada Approves Sprycel™, a New Treatment for Chronic Myeloid Leukemia

  Molecular breakthrough offers new hope for patients with life-threatening form of blood cancer who fail or intolerant to current therapies

  Categories: Chronic myeloid leukemia (CML) | Sprycel